Philip G. Strange

5.9k total citations
181 papers, 4.7k citations indexed

About

Philip G. Strange is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Animal Science and Zoology. According to data from OpenAlex, Philip G. Strange has authored 181 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 109 papers in Cellular and Molecular Neuroscience and 19 papers in Animal Science and Zoology. Recurrent topics in Philip G. Strange's work include Receptor Mechanisms and Signaling (116 papers), Neurotransmitter Receptor Influence on Behavior (66 papers) and Neuroscience and Neuropharmacology Research (47 papers). Philip G. Strange is often cited by papers focused on Receptor Mechanisms and Signaling (116 papers), Neurotransmitter Receptor Influence on Behavior (66 papers) and Neuroscience and Neuropharmacology Research (47 papers). Philip G. Strange collaborates with scholars based in United Kingdom, United States and Canada. Philip G. Strange's co-authors include Anja Müeller, David A. Hall, Duncan Armstrong, Alan T. Bull, Anthony J. Baines, Daniel E. Koshland, Sarah A. Nickolls, Eamonn Kelly, Louise H. Naylor and Nigel Jenkins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Philip G. Strange

178 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip G. Strange United Kingdom 41 3.3k 2.5k 373 364 268 181 4.7k
Terence E. Hébert Canada 45 6.1k 1.8× 3.5k 1.4× 446 1.2× 307 0.8× 326 1.2× 180 7.8k
Carmen Lluís Spain 45 3.3k 1.0× 2.8k 1.1× 207 0.6× 363 1.0× 378 1.4× 86 5.6k
Josefa Mallol Spain 54 4.3k 1.3× 3.4k 1.4× 256 0.7× 599 1.6× 483 1.8× 124 7.3k
Yasuji Furutani Japan 23 3.1k 0.9× 2.0k 0.8× 251 0.7× 441 1.2× 305 1.1× 34 4.9k
Carl D. Bennett United States 29 3.0k 0.9× 1.2k 0.5× 230 0.6× 289 0.8× 287 1.1× 58 4.3k
John K. Northup United States 42 5.4k 1.6× 2.0k 0.8× 245 0.7× 417 1.1× 390 1.5× 84 7.1k
Nevin A. Lambert United States 45 4.6k 1.4× 2.8k 1.1× 371 1.0× 287 0.8× 281 1.0× 105 6.0k
Jeffrey M. Stadel United States 39 4.1k 1.2× 2.1k 0.9× 318 0.9× 519 1.4× 528 2.0× 83 5.8k
Francesca Fanelli Italy 39 4.6k 1.4× 2.5k 1.0× 530 1.4× 224 0.6× 208 0.8× 164 6.1k
Andrew B. Tobin United Kingdom 44 4.1k 1.2× 2.1k 0.8× 302 0.8× 385 1.1× 284 1.1× 141 5.5k

Countries citing papers authored by Philip G. Strange

Since Specialization
Citations

This map shows the geographic impact of Philip G. Strange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Strange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Strange more than expected).

Fields of papers citing papers by Philip G. Strange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Strange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Strange. The network helps show where Philip G. Strange may publish in the future.

Co-authorship network of co-authors of Philip G. Strange

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Strange. A scholar is included among the top collaborators of Philip G. Strange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Strange. Philip G. Strange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strange, Philip G., et al.. (2021). Effect of cranberry pomace on the physicochemical properties and inactivation of Salmonella during the manufacture of dry fermented sausages. Current Research in Food Science. 4. 636–645. 11 indexed citations
2.
Radford, Devon, Philip G. Strange, Dion Lepp, et al.. (2018). Genomic and Proteomic Analyses of Salmonella enterica Serovar Enteritidis Identifying Mechanisms of Induced de novo Tolerance to Ceftiofur. Frontiers in Microbiology. 9. 2123–2123. 11 indexed citations
3.
Newton, Claire, Martyn Wood, & Philip G. Strange. (2016). Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors. PLoS ONE. 11(7). e0158808–e0158808. 9 indexed citations
4.
Singh, Shweta, Elodie Kara, So Iwata, et al.. (2010). A purified C-terminally truncated human adenosine A2A receptor construct is functionally stable and degradation resistant. Protein Expression and Purification. 74(1). 80–87. 21 indexed citations
5.
Vivó, Meritxell, et al.. (2005). Investigation of Cooperativity in the Binding of Ligands to the D2 Dopamine Receptor. Molecular Pharmacology. 69(1). 226–235. 38 indexed citations
6.
Roberts, David J., Hong Lin, & Philip G. Strange. (2004). Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors. Biochemical Pharmacology. 67(9). 1657–1665. 18 indexed citations
7.
Müeller, Anja & Philip G. Strange. (2003). The chemokine receptor, CCR5. The International Journal of Biochemistry & Cell Biology. 36(1). 35–38. 91 indexed citations
8.
Welsh, Gavin I., et al.. (1998). Activation of Microtubule‐Associated Protein Kinase (Erk) and p70 S6 Kinase by D2 Dopamine Receptors. Journal of Neurochemistry. 70(5). 2139–2146. 73 indexed citations
9.
Sundaram, Hardy, Adrian Newman‐Tancredi, & Philip G. Strange. (1993). Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese Hamster Ovary cells. Biochemical Pharmacology. 45(5). 1003–1009. 43 indexed citations
10.
Chazot, Paul L. & Philip G. Strange. (1992). Molecular characterization of D2 dopamine-like receptors from brain and from the pituitary gland. Neurochemistry International. 21(2). 159–169. 1 indexed citations
11.
Strange, Philip G., et al.. (1992). Studies on the structure of the ligand-binding site of the brain D1 dopamine receptor. Biochemical Pharmacology. 44(2). 325–334. 7 indexed citations
12.
Strange, Philip G.. (1990). Aspects of the structure of the D2 dopamine receptor. Trends in Neurosciences. 13(9). 373–378. 40 indexed citations
13.
Strange, Philip G.. (1990). Reply. Trends in Neurosciences. 13(8). 324–325. 4 indexed citations
14.
Marriott, A.S., et al.. (1988). D2 dopamine receptors in rat striatum are homogeneous as revealed by ligand-binding studies. Biochemical Pharmacology. 37(22). 4335–4339. 7 indexed citations
15.
Strange, Philip G., et al.. (1987). Monoclonal antibodies directed against the drug haloperidol. Neurochemistry International. 11(4). 389–395. 3 indexed citations
16.
Strange, Philip G.. (1987). Dopamine receptors in the brain and periphery: “state of the art”. Neurochemistry International. 10(1). 27–33. 11 indexed citations
17.
Milligan, Graeme & Philip G. Strange. (1984). Use of [3H]Triphenylmethylphosphomum Cation for Estimating Membrane Potential in Neuroblastoma Cells. Journal of Neurochemistry. 43(6). 1515–1521. 8 indexed citations
18.
Wheatley, Mark & Philip G. Strange. (1983). Effect of incubation temperature on (3H) spiperone binding to solubilised neurotransmitter receptors. British Journal of Pharmacology. 78. 1 indexed citations
19.
Milligan, Graeme & Philip G. Strange. (1983). Reduction in accumulation of [3H]triphenylmethylphosphonium cation in neuroblastoma cells caused by optical probes of membrane potential. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 762(4). 585–592. 4 indexed citations
20.
Milligan, Graeme & Philip G. Strange. (1982). The use of lipophilic anions to facilitate uptake of triphenylmethylphosphonium cation in membrane-potential studies in neuroblastoma cells. Biochemical Society Transactions. 10(5). 375–376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terence E. Hébert Breakdown of academic impact, for papers by Carmen Lluís Breakdown of academic impact, for papers by Josefa Mallol Breakdown of academic impact, for papers by Yasuji Furutani Breakdown of academic impact, for papers by Carl D. Bennett Breakdown of academic impact, for papers by John K. Northup Breakdown of academic impact, for papers by Nevin A. Lambert Breakdown of academic impact, for papers by Jeffrey M. Stadel Breakdown of academic impact, for papers by Francesca Fanelli Breakdown of academic impact, for papers by Andrew B. Tobin
Rankless by CCL
2026